Transcenta Announces Updated Board Composition and Committee Structure

Bulletin Express
06/30

Transcenta Holding Limited released an updated list of directors and their respective committee roles, confirming the governance framework in place as of 30 June 2026.

Executive Leadership • Dr. Xueming Qian serves as Chief Executive Officer, Chairman of the Board, and Chairperson of the Nomination Committee.

Non-Executive Directors • Dr. Li Xu • Dr. Hansen Xu

Independent Non-Executive Directors • Mr. Jiasong Tang • Ms. Helen Wei Chen

Board Committee Assignments 1. Audit Committee – Chairperson: Mr. Jiasong Tang – Members: Dr. Li Xu and Dr. Hansen Xu

2. Remuneration Committee – Chairperson: Ms. Helen Wei Chen – Members: Dr. Li Xu and Dr. Hansen Xu

3. Nomination Committee – Chairperson: Dr. Xueming Qian – Members: Mr. Jiasong Tang and Ms. Helen Wei Chen

The announcement confirms that all three committees—Audit, Remuneration and Nomination—are chaired by independent directors or the Chairman of the Board, reflecting adherence to corporate governance best practices. The Board composition comprises one executive director, two non-executive directors and two independent non-executive directors.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10